Dr. Brannan is a neuroscience drug development expert who has held senior positions overseeing both clinical development and medical affairs with more than 15 years of industry experience. Previously, Dr. Brannan was the Therapeutic Head of Neuroscience at Takeda and Vice President for Clinical Research and Medical Affairs at Forum Pharmaceuticals. Dr. Brannan has been active in the development of multiple important central nervous system treatments including Cymbalta®, Exelon Patch®, Trintellix®, and Vagal Nerve Stimulation for Treatment Resistant Depression while holding various senior roles at Forum, Takeda, Novartis, Cyberonics, and Eli Lilly. His experience includes drug development, registration, medical affairs, launch and lifecycle management across psychiatry and neurology programs. Dr. Brannan is a member of several scientific societies and groups, including ACNP, ISCTM (member of the Executive and Scientific Program Committees), ISCDD, AARR, IOM Neuroforum, and CNS Summit (founding member and member of the Leadership Council).
Prior to joining the pharmaceutical industry, Dr. Brannan worked on the faculty at the University of Texas Health Science Center at San Antonio (UTHSCSA) where he specialized in seeing mood and anxiety disorder patients, ran a clinical research unit, and did neuroimaging research at the Research Imaging Center.
Dr. Brannan trained in psychiatry at UTHSCSA and holds an M.D. from the University of Texas Health Science Center at Dallas (Southwestern Medical School). He has over 40 publications and routinely gives invited talks and presentations at industry conferences.
What is Stephen K. Brannan's net worth?
The estimated net worth of Stephen K. Brannan is at least $14.05 million as of March 8th, 2024. Dr. Brannan owns 42,604 shares of Karuna Therapeutics stock worth more than $14,052,077 as of November 22nd. This net worth evaluation does not reflect any other investments that Dr. Brannan may own. Additionally, Dr. Brannan receives an annual salary of $751,750.00 as Insider at Karuna Therapeutics. Learn More about Stephen K. Brannan's net worth.
How old is Stephen K. Brannan?
What is Stephen K. Brannan's salary?
As the Insider of Karuna Therapeutics, Inc., Dr. Brannan earns $751,750.00 per year. The highest earning executive at Karuna Therapeutics is Dr. Andrew Craig Miller Ph.D., Founder and President of Research & Development, who commands a salary of $835,400.00 per year. Learn More on Stephen K. Brannan's salary.
How do I contact Stephen K. Brannan?
Has Stephen K. Brannan been buying or selling shares of Karuna Therapeutics?
Stephen K. Brannan has not been actively trading shares of Karuna Therapeutics over the course of the past ninety days. Most recently, Stephen K. Brannan sold 5,000 shares of the business's stock in a transaction on Friday, March 8th. The shares were sold at an average price of $318.34, for a transaction totalling $1,591,700.00. Following the completion of the sale, the insider now directly owns 42,604 shares of the company's stock, valued at $13,562,557.36. Learn More on Stephen K. Brannan's trading history.
Who are Karuna Therapeutics' active insiders?
Are insiders buying or selling shares of Karuna Therapeutics?
In the last twelve months, insiders at the sold shares 4 times. They sold a total of 35,000 shares worth more than $9,948,200.00. The most recent insider tranaction occured on March, 8th when insider Stephen K Brannan sold 5,000 shares worth more than $1,591,700.00. Insiders at Karuna Therapeutics own 13.2% of the company.
Learn More about insider trades at Karuna Therapeutics. Information on this page was last updated on 3/8/2024.
